CPC A61K 31/454 (2013.01) [A61K 9/1652 (2013.01); A61K 9/5026 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01)] | 15 Claims |
1. A pharmaceutical composition in the form of a tablet comprising the following components on a weight percentage basis:
(i) in an intragranular portion:
(a) 40-50% of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole 7-carboxamide 4-methylbenzenesulfonate monohydrate;
(b) 9-11% of a first diluent;
(c) 30-40% of a second diluent;
(d) 1-3% of a binder;
(e) 0.1-2% of a disintegrant;
(f) 2-4% of a glidant, adsorbent, or absorbent; and
(g) 0.1-2% of a lubricant; and
(ii) in an extragranular portion:
(a) 0.1-2% of a disintegrant;
(b) 0.1-2% of a glidant, adsorbent, or absorbent; and
(c) 0.1-2% of a lubricant.
|